Marco's Morning Report — Tuesday, July 21, 2026

A · Top Stories

Update: Iran war hits its 10th night — Tehran strikes Kuwait, Bahrain and Jordan; two tankers ablaze in Hormuz

The US ran a tenth consecutive night of strikes across Iran, and Tehran widened its retaliation well beyond the battlefield: the IRGC says it hit US assets in Jordan, Bahrain and Kuwait, and two tankers are burning in the Strait of Hormuz. The fight remains anchored on control of Hormuz — roughly a fifth of global energy exports moved through it before the war — with Trump pushing to force prices down ahead of the midterms and Iran insisting shipping hug its coastline. Tehran continues to call the June memorandum void and says it's in an "existential war."

Why it matters to you: The oil shock is no longer abstract. A sustained squeeze on Hormuz feeds hospital operating costs and raises real risk of generic-injectable and IV-fluid supply pressure, since much of that API/finished-drug supply chain runs through the region. Rising pump prices also quietly pressure commute costs and overtime economics on a nocturnist rota.

Watch: keep an eye out for pharmacy or supply-chain memos on shortages or substitutions over the coming weeks — better to flag proactively at a group huddle than get surprised mid-shift. Al Jazeera live (Jul 21)

Houthis declare a naval blockade of Saudi Arabia — another chokepoint on the global energy map

Yemen's Houthis announced an immediate maritime blockade of Saudi Arabia, framed as retaliation ("an eye for an eye") for last week's attack on Sanaa International Airport. It targets Saudi shipping through the Red Sea and Bab al-Mandeb, where total petroleum volumes ran about 7.4 million barrels per day in June — roughly 7% of global oil output. Saudi exports from Yanbu had surged to ~4 million bpd recently as shippers rerouted around Hormuz; this move squeezes the alternative route too. Analysts are calling it a "significant military move" against global trade.

Why it matters to you: This is the second-order story behind the first card. With both Hormuz and Bab al-Mandeb now contested, the "just reroute the oil" safety valve narrows — which keeps the supply-cost and drug-shortage risk elevated rather than transient.

Talking point: if colleagues ask why energy and supply worries aren't easing, this is the reason — the war now touches two of the world's key oil chokepoints at once. Al Jazeera explainer

B · The Debate

Are Florida's insurance reforms actually working — or do homeowners need a hard cap on rate hikes?

Why it's live right now: A batch of the 2026 property-insurance changes took effect July 1, and Gov. DeSantis has been touting "major rate relief" — Citizens cutting rates ~8.7% this spring, 17 new carriers entering, private reductions of 5–8%. Consumer advocates counter that relief is thin and uneven, pointing to a ~46.7% claim-denial rate in 2024 (heavy with Hurricane Milton losses), and Sen. Barbara Sharief's SB 30 would cap annual increases at 10–15% and arm the state Insurance Consumer Advocate with subpoena power.

The case FOR (reforms are working — don't meddle)

The market is healing because the 2022–23 tort reforms worked, argues the DeSantis administration alongside industry groups like the Personal Insurance Federation of Florida: litigation costs that once drove Florida's premiums to the highest in the nation have fallen, seventeen new insurers have entered, and Citizens is cutting rates rather than raising them. Impose a hard rate cap now, they warn, and you scare off the very carriers that just came back — recreating the coverage-of-last-resort spiral the state spent years digging out of. Give the reforms time to compound.

The case AGAINST (relief is thin — cap the hikes)

Averages hide the pain, counter legislative Democrats led by Sen. Barbara Sharief, whose SB 30 would cap annual increases at 10–15% and give the Consumer Advocate real teeth. A single-digit Citizens cut means little when many homeowners still face four- and five-figure premiums and a claim-denial rate near half; "the market is stabilizing" reads differently to a family whose renewal jumped again. Consumers, they argue, need enforceable guardrails now — not the promise that competition will eventually deliver.

Where it might land: with GOP leaders crediting tort reform and wary of new mandates, rate-cap bills like SB 30 face long odds — but affordability is squarely atop the 2026 session agenda.

C · On My Radar

Medicine desk — quiet. No new practice-changing hospitalist, internal-medicine, or family-medicine guidance in the last 24–48h, and USPSTF is still dark (July meeting pushed to late August). Lean on the existing sepsis / delirium / metformin items in Background below.

Mets, still selling. Two weeks out from the Aug. 3 deadline, the Mets (~41–57) remain full sellers — everyone but Soto and the young core is available. White Sox have a scout "keeping tabs" on Clay Holmes, though there's mutual interest in an extension; if no deal, he's likely moved. David Peterson already went to the Cubs. Yahoo Sports

Puerto Rico grid readiness. Ahead of peak-summer demand, LUMA says its Customer Battery Energy Sharing program now spans 90,000+ customers and can add ~75 MW during shortfalls, part of the $5B ($1.8B underway) FEMA-backed overhaul replacing 70-year-old transformers. The catch: PREPA underfunded operations ~70% in FY24–25, so the grid stays fragile. LUMA

Golf gear: Shot Scope's standalone $200 LM1 — the 2026 PGA Show "Best of Show" — is the value pick in a crowded budget launch-monitor race (Blue Tees Rainmaker $599, Square Omni $1,599 for indoor/outdoor). No apps, ~25 seconds from power-on to first shot. Plugged In Golf

Queue-worthy: A24's The Invite is still the year's best-reviewed film (mid-90s on Rotten Tomatoes), and Silo S3 is landing its finale as "science-fiction excellence." Nolan's The Odyssey keeps drawing crowds if you want the big-screen swing. Rotten Tomatoes

D · Trends to Watch

Two chokepoints, one oil shock. With Hormuz contested and Bab al-Mandeb now under a Houthi blockade, the reroute-around-the-trouble strategy is running out of road. The slow-burn hospital story — generic-injectable shortages, supply-cost inflation, staffing/overtime pressure — gets more likely the longer both stay hot.

Clinical AI adoption still outrunning validation. The throughline from this week's scribe debate holds: tools are deploying faster than anyone's validating them, with liability drifting onto the signing clinician. "Who owns the error" is becoming the real governance question.

Delirium prevention as a measured metric. The 2026 inpatient-geriatrics throughline continues — risk-stratify at admission, deprescribe deliriogenic meds, mobilize early, protect sleep, screen with a validated tool, reserve antipsychotics for genuine danger. Steadily shifting from "good practice" toward a tracked safety standard.

E · Ideas & Opportunities

Post-shift watch: queue The Invite (A24) for a wind-down, or start Silo S3 if you want a series to sink into across a few nights off.

Supply-chain heads-up: given the two-chokepoint squeeze, it's a reasonable week to ask your pharmacy contact whether any injectables or IV fluids are on watch — a two-minute question now beats a scramble mid-shift.

Home front: with the July 1 insurance changes live, your own renewal is worth a glance — the reforms may (or may not) show up in your Cape Coral premium this cycle.

H · Background / Already Covered

Earlier items still worth having on hand (tap to expand)

Cuba's grid crisis: the island's third nationwide blackout of the year (~10M in the dark) as fuel reserves ran dry — transport halted, tens of thousands of surgeries canceled. No major new development in the last 48h beyond the ongoing recovery.
2026 Surviving Sepsis Campaign (SCCM/ESICM): screen acutely ill inpatients with NEWS/NEWS2/MEWS or SIRS over qSOFA; initial MAP target 65 mmHg; 129 statements, 46 new. Worth a pass for your sepsis order set.
The Hospitalist (July issue): continue metformin when eGFR >30 (lower 90-day mortality/readmission), stop albumin-correcting calcium, consider urea for SIADH.
APA delirium guideline (first update in 25 years): non-pharmacologic prevention, structured screening, against routine antipsychotics — the evidence base behind the "prevent-at-admission" trend above.
SHM 2026 Workforce report: 64% of hospitalists now use AI in practice; 73% report a benefit — context for this week's ambient-scribe debate.
Iran war backstory: the June memorandum broke down after Iran struck ships in Hormuz on July 8; the US reimposed a naval blockade of Iranian ports mid-month. Section A carries the current escalation.